| Quarterly Financials | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 103 | 118 | 116 | 140 | 175 | 191 | 224 | 219 |
| Expenses | 75 | 74 | 86 | 94 | 96 | 98 | 121 | 138 |
| EBITDA | 28 | 44 | 30 | 46 | 80 | 94 | 103 | 81 |
| Operating Profit % | 25 % | 35 % | 26 % | 33 % | 45 % | 48 % | 45 % | 36 % |
| Depreciation | 5 | 6 | 9 | 9 | 10 | 10 | 11 | 16 |
| Interest | 2 | 2 | 4 | 3 | 2 | 4 | 3 | 4 |
| Profit Before Tax | 21 | 35 | 18 | 34 | 69 | 79 | 89 | 61 |
| Tax | 5 | 9 | 5 | 9 | 17 | 20 | 22 | 16 |
| Net Profit | 16 | 27 | 13 | 25 | 51 | 59 | 67 | 45 |
| EPS in ₹ | 1.27 | 2.14 | 1.06 | 2.04 | 4.12 | 4.73 | 5.36 | 3.63 |
Jeena Sikho Lifecare
Jeena Sikho Lifecare
602.35
-11.90
(-1.94%)
Market Cap
7,487.25 Cr
PE Ratio
34.44
Volume
17,20,796.00
Day High - Low
629.40 - 592.90
52W High-Low
2,310.00 - 400.25
Company has added their latest Transcript1 day ago
View
Key Fundamentals
Market Cap
7,487.25 Cr
EPS
17.84
PE Ratio
34.44
PB Ratio
16.35
Book Value
37.58
EBITDA
349.42
Dividend Yield
0.73 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
26.65
Debt to Equity
0.05
Actual
Company News
View All News
Jeena Sikho Lifecare Limited will hold an investor/analyst meet on June 12, 2026. The virtual conference is organized by Choice Institutional Equities.
Jeena Sikho Lifecare's Bhopal Hospital Earns NABH Accreditation6 days ago
Jeena Sikho Lifecare's Bhopal hospital has received NABH accreditation for its Panchakarma services, with validity extending until May 2029.
Jeena Sikho publishes 13 medical case studies
May 25, 2026
May 25, 2026Jeena Sikho Lifecare Limited published 13 case studies and reports in medical journals on May 25, 2026, authored by its Managing Director and experts.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,779.00 | #1 4,26,841.69 | 37.29 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 42.95 | |
6,753.00 | 1,79,270.93 | 67.37 | 10,560.00 | 8.73 | 2,520 | 13.44 | 56.37 | |
4,472.90 | 1,51,383.26 | 69.83 | 13,886.20 | 20.34 | 2,138 | -26.91 | 56.32 | |
1,105.60 | 1,11,249.23 | 21.36 | 26,719.70 | 13.65 | 5,242 | 7.82 | 73.53 | |
1,376.50 | 1,11,191.01 | 29.04 | 29,044.60 | 2.24 | 3,870 | -55.32 | 51.31 | |
1,268.50 | 1,05,874.47 | 25.61 | 33,593.30 | -0.44 | 3,998 | -86.05 | 43.38 | |
2,264.20 | 1,03,483.73 | #1 19.23 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 46.79 | |
2,391.00 | 98,701.69 | 50.24 | 14,277.60 | 12.03 | 1,750 | 31.75 | 53.06 | |
1,449.00 | 84,158.16 | 24.07 | 33,384.70 | 3.21 | 3,376 | 1.99 | 50.33 | |
1,424.40 | 76,897.17 | 85.23 | 6,812.90 | #1 21.03 | 884 | 21.18 | 70.54 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
286.57 %
Net Income Growth
548.00 %
Cash Flow Change
-11.19 %
ROE
-13.14 %
ROCE
-17.44 %
EBITDA Margin (Avg.)
85.59 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2026 |
| Total Assets | 62 | 151 | 674 |
| Fixed Assets | 29 | 60 | 238 |
| Current Assets | 22 | 78 | 341 |
| Capital Work in Progress | 5 | 1 | 2 |
| Investments | 0 | 5 | 20 |
| Other Assets | 28 | 86 | 0 |
| Total Equity & Liabilities | 62 | 151 | 674 |
| Current Liabilities | 24 | 25 | 105 |
| Non Current Liabilities | 1 | 1 | 102 |
| Total Equity | 37 | 126 | 467 |
| Reserve & Surplus | 26 | 112 | 442 |
| Share Capital | 10 | 14 | 25 |
Cash Flow
| Cash Flow | 2022 | 2023 |
| Net Cash Flow | -7 | 29 |
| Investing Activities | -19 | -33 |
| Operating Activities | 16 | 15 |
| Financing Activities | -5 | 48 |
Share Holding
| % Holding | Sept 2021 | Feb 2022 | Apr 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Nov 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 90.00 % | 90.00 % | 65.89 % | 65.89 % | 66.20 % | 67.91 % | 67.91 % | 67.91 % | 65.84 % | 63.53 % | 63.53 % | 63.53 % | 63.61 % | 63.62 % | 63.62 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 5.99 % | 6.59 % | 6.31 % | 6.17 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.18 % | 0.15 % | 0.11 % | 0.46 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 10.00 % | 10.00 % | 20.05 % | 16.21 % | 15.28 % | 14.41 % | 14.94 % | 17.34 % | 16.72 % | 16.67 % | 17.05 % | 17.20 % | 17.32 % | 18.19 % | 18.37 % |
| Others | 0.00 % | 0.00 % | 14.06 % | 17.90 % | 18.52 % | 17.68 % | 17.15 % | 14.75 % | 17.44 % | 19.80 % | 19.41 % | 13.10 % | 12.33 % | 11.76 % | 11.38 % |
| No of Share Holders | 7 | 6 | 1,951 | 834 | 663 | 814 | 1,107 | 2,721 | 3,423 | 5,967 | 6,603 | 7,434 | 16,362 | 22,181 | 25,905 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.47 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Aug 2023 |  Dividend | ₹ 2.00 /share | 25 Aug 2023 | 333.00 | 1,065.05 |
| 02 Nov 2023 |  Bonus | 4:5 | 02 Nov 2023 | 1,195.50 | 1,403.25 |
| 27 Feb 2024 |  Extraordinary General Meeting | NA | 27 Feb 2024 | 641.00 | 857.80 |
| 20 Aug 2024 | Dividend | ₹ 4.18 /share | 20 Aug 2024 | 1,121.40 | 1,416.40 |
| 28 Aug 2024 |  Annual General Meeting | NA | 28 Aug 2024 | 1,147.00 | 1,351.20 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 1,723.10 | 1,706.30 |
| 16 May 2025 | Quarterly Result Announcement | NA | 16 May 2025 | 2,284.55 | 2,353.90 |
| 21 Apr 2025 |  Split | 2:10 | 12 Jun 2025 | 2,251.25 | 2,251.25 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 547.35 | 560.70 |
| 22 Sept 2025 | Dividend | ₹ 1.10 /share | 22 Sept 2025 | 2,353.90 | 817.80 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 702.30 | 802.15 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 743.80 | 782.00 |
| 07 Feb 2026 | Quarterly Result Announcement | NA | 07 Feb 2026 | 649.70 | 710.95 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 649.60 | 614.90 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation15 hrs ago
15 hrs agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript1 day ago
1 day agoJeena Sikho Lifecare Limited Has Informed The Exchange About Receipt Of NABH Accreditation For Bhopal Hospital.6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Dividend Updates10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Change in Management10 days ago
10 days agoCorporate Action-Board approves Dividend10 days ago
10 days agoDeclaration Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March 202610 days ago
10 days agoBoard Meeting Outcome for Declaration Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March 2026.10 days ago
10 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2026
May 27, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Studies And Case Reports.May 25, 2026
May 25, 2026Corporate Action-Board to consider DividendMay 21, 2026
May 21, 2026Board Meeting Intimation for Prior Intimation Of Meeting Of Board Of Directors Scheduled To Be Held On Saturday 30Th Day Of May 2026May 21, 2026
May 21, 2026Revised Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing
Regulations) - Sale Of LandMay 09, 2026
May 09, 2026Sale Of Land - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.May 08, 2026
May 08, 2026Intimation For Appointment Of Investor Relations Management Agency Of The CompanyMay 04, 2026
May 04, 2026 Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Study And Case Reports.May 04, 2026
May 04, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 16, 2026
Apr 16, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Receipt Of NABH Accreditation For Noida Hospital.Apr 15, 2026
Apr 15, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2026
Apr 03, 2026Closure of Trading WindowMar 23, 2026
Mar 23, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Study And Case Reports.Mar 23, 2026
Mar 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2026
Mar 17, 2026Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information.Mar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 06, 2026
Mar 06, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Studies And Case Report.Feb 23, 2026
Feb 23, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Receipt Of NABH Certificate Of Accreditation For Dehradun Hospital.Feb 19, 2026
Feb 19, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Proposal For Establishment Of New Hospital In Ahmedabad.Feb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 08, 2026
Feb 08, 2026Jeena Sikho Lifecare Limited Has Submitted To The Exchange The Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report Thereon For The Quarter And Nine Months Ended December 31 2025.Feb 07, 2026
Feb 07, 2026Board Meeting Outcome for Jeena Sikho Lifecare Limited Has Submitted To The Exchange The Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report Thereon For The Quarter And Nine Months Ended December 31 2025.Feb 07, 2026
Feb 07, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Commencement Of Operation Of Hospitals In Siliguri West Bengal And Bhagalpur Bihar.Feb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Feb 04, 2026Board Meeting Intimation for To Inter Alia Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 31St December 2025 Along With The Limited Review Report Thereon.
Feb 03, 2026
Feb 03, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case ReportJan 22, 2026
Jan 22, 2026Board Meeting Outcome for Jeena Sikho Lifecare Limited Has Informed The Exchange Regarding Outcome Of Board Meeting Held On January 21 2026-Approval Of Loan Agreement With Jeena Sikho International LLC A Wholly Owned Subsidiary ( WOS ) Of The Company.Jan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-AcquisitionJan 16, 2026
Jan 16, 2026Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Procurement Agreement With Theryco Healthcare Solutions Private LimitedJan 13, 2026
Jan 13, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Study And Research Article.Jan 12, 2026
Jan 12, 2026Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Studies And Case Reports.Jan 07, 2026
Jan 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Jan 05, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Angel One Nifty Total Market Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.01% | |
 Bandhan Nifty Total Market Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.02% | |
 Groww Nifty Total Market Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.02% | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.02% | |
 Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.38% |
Technical Indicators
RSI(14)
Neutral 46.27
ATR(14)
Less Volatile 53.96
STOCH(9,6)
Neutral 51.32
STOCH RSI(14)
Neutral 78.40
MACD(12,26)
Bearish -1.16
ADX(14)
Weak Trend 16.07
UO(9)
Bearish 40.66
ROC(12)
Downtrend And Accelerating -5.59
WillR(14)
Neutral -52.55
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
